Cargando…

Effect of scheduled endoscopic dilatation of dominant strictures on outcome in patients with primary sclerosing cholangitis

OBJECTIVE: Scheduled endoscopic dilatation of dominant strictures (DS) in primary sclerosing cholangitis (PSC) might improve outcome relative to endoscopic treatment on demand, but evidence is limited. Since randomisation is difficult in clinical practice, we present a large retrospective study comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Rupp, Christian, Hippchen, Theresa, Bruckner, Thomas, Klöters-Plachky, Petra, Schaible, Anja, Koschny, Ronald, Stiehl, Adolf, Gotthardt, Daniel Nils, Sauer, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872453/
https://www.ncbi.nlm.nih.gov/pubmed/30910856
http://dx.doi.org/10.1136/gutjnl-2018-316801
_version_ 1783472492080267264
author Rupp, Christian
Hippchen, Theresa
Bruckner, Thomas
Klöters-Plachky, Petra
Schaible, Anja
Koschny, Ronald
Stiehl, Adolf
Gotthardt, Daniel Nils
Sauer, Peter
author_facet Rupp, Christian
Hippchen, Theresa
Bruckner, Thomas
Klöters-Plachky, Petra
Schaible, Anja
Koschny, Ronald
Stiehl, Adolf
Gotthardt, Daniel Nils
Sauer, Peter
author_sort Rupp, Christian
collection PubMed
description OBJECTIVE: Scheduled endoscopic dilatation of dominant strictures (DS) in primary sclerosing cholangitis (PSC) might improve outcome relative to endoscopic treatment on demand, but evidence is limited. Since randomisation is difficult in clinical practice, we present a large retrospective study comparing scheduled versus on-demand endoscopic retrograde cholangiopancreatography (ERCP) based on patient preferences. DESIGN: Between 1987 and 2017, all new patients with PSC had been offered scheduled ERCP with dilatation of a DS if diagnosed; the latter was repeated at defined intervals until morphological resolution, independent of clinical symptoms (treatment group). Patients who refused participation were clinically evaluated annually and received endoscopic treatment only on demand (control group). The primary clinical endpoint was transplantation-free survival. Secondary outcomes were overall survival, bacterial cholangitis episodes, hepatic decompensation of liver cirrhosis and endoscopy-related adverse events. RESULTS: The final study included 286 patients, 133 (46.5%) receiving scheduled ERCP and 153 (53.5%) receiving on-demand ERCP. After a mean follow-up of 9.9 years, the rate of transplantation-free survival was higher in patients receiving scheduled ERCP (51% vs 29.3%; p<0.001), as was transplantation-free survival time (median: 17.9 vs 15.2 years; log-rank: p=0.008). However, the benefit of scheduled ERCP was significant only in patients with the initial (17.1%) or later (45.5%) diagnosis of a DS (17.8 vs 11.1 years; log-rank: p<0.001). IBD (p=0.03), DS (p=0.006), higher Mayo Risk Score (p=0.02) and non-adherence to scheduled endoscopy (p=0.005) were independently associated with transplantation-free survival. CONCLUSION: In our large retrospective study, regular ERCP with endoscopic balloon dilatation significantly benefits patients with PSC with DS, diagnosed both at initial presentation and during surveillance, even if asymptomatic. Further studies have to find out how to best identify stricture patients non-invasively.
format Online
Article
Text
id pubmed-6872453
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-68724532019-12-04 Effect of scheduled endoscopic dilatation of dominant strictures on outcome in patients with primary sclerosing cholangitis Rupp, Christian Hippchen, Theresa Bruckner, Thomas Klöters-Plachky, Petra Schaible, Anja Koschny, Ronald Stiehl, Adolf Gotthardt, Daniel Nils Sauer, Peter Gut Endoscopy OBJECTIVE: Scheduled endoscopic dilatation of dominant strictures (DS) in primary sclerosing cholangitis (PSC) might improve outcome relative to endoscopic treatment on demand, but evidence is limited. Since randomisation is difficult in clinical practice, we present a large retrospective study comparing scheduled versus on-demand endoscopic retrograde cholangiopancreatography (ERCP) based on patient preferences. DESIGN: Between 1987 and 2017, all new patients with PSC had been offered scheduled ERCP with dilatation of a DS if diagnosed; the latter was repeated at defined intervals until morphological resolution, independent of clinical symptoms (treatment group). Patients who refused participation were clinically evaluated annually and received endoscopic treatment only on demand (control group). The primary clinical endpoint was transplantation-free survival. Secondary outcomes were overall survival, bacterial cholangitis episodes, hepatic decompensation of liver cirrhosis and endoscopy-related adverse events. RESULTS: The final study included 286 patients, 133 (46.5%) receiving scheduled ERCP and 153 (53.5%) receiving on-demand ERCP. After a mean follow-up of 9.9 years, the rate of transplantation-free survival was higher in patients receiving scheduled ERCP (51% vs 29.3%; p<0.001), as was transplantation-free survival time (median: 17.9 vs 15.2 years; log-rank: p=0.008). However, the benefit of scheduled ERCP was significant only in patients with the initial (17.1%) or later (45.5%) diagnosis of a DS (17.8 vs 11.1 years; log-rank: p<0.001). IBD (p=0.03), DS (p=0.006), higher Mayo Risk Score (p=0.02) and non-adherence to scheduled endoscopy (p=0.005) were independently associated with transplantation-free survival. CONCLUSION: In our large retrospective study, regular ERCP with endoscopic balloon dilatation significantly benefits patients with PSC with DS, diagnosed both at initial presentation and during surveillance, even if asymptomatic. Further studies have to find out how to best identify stricture patients non-invasively. BMJ Publishing Group 2019-12 2019-03-25 /pmc/articles/PMC6872453/ /pubmed/30910856 http://dx.doi.org/10.1136/gutjnl-2018-316801 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Endoscopy
Rupp, Christian
Hippchen, Theresa
Bruckner, Thomas
Klöters-Plachky, Petra
Schaible, Anja
Koschny, Ronald
Stiehl, Adolf
Gotthardt, Daniel Nils
Sauer, Peter
Effect of scheduled endoscopic dilatation of dominant strictures on outcome in patients with primary sclerosing cholangitis
title Effect of scheduled endoscopic dilatation of dominant strictures on outcome in patients with primary sclerosing cholangitis
title_full Effect of scheduled endoscopic dilatation of dominant strictures on outcome in patients with primary sclerosing cholangitis
title_fullStr Effect of scheduled endoscopic dilatation of dominant strictures on outcome in patients with primary sclerosing cholangitis
title_full_unstemmed Effect of scheduled endoscopic dilatation of dominant strictures on outcome in patients with primary sclerosing cholangitis
title_short Effect of scheduled endoscopic dilatation of dominant strictures on outcome in patients with primary sclerosing cholangitis
title_sort effect of scheduled endoscopic dilatation of dominant strictures on outcome in patients with primary sclerosing cholangitis
topic Endoscopy
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872453/
https://www.ncbi.nlm.nih.gov/pubmed/30910856
http://dx.doi.org/10.1136/gutjnl-2018-316801
work_keys_str_mv AT ruppchristian effectofscheduledendoscopicdilatationofdominantstricturesonoutcomeinpatientswithprimarysclerosingcholangitis
AT hippchentheresa effectofscheduledendoscopicdilatationofdominantstricturesonoutcomeinpatientswithprimarysclerosingcholangitis
AT brucknerthomas effectofscheduledendoscopicdilatationofdominantstricturesonoutcomeinpatientswithprimarysclerosingcholangitis
AT klotersplachkypetra effectofscheduledendoscopicdilatationofdominantstricturesonoutcomeinpatientswithprimarysclerosingcholangitis
AT schaibleanja effectofscheduledendoscopicdilatationofdominantstricturesonoutcomeinpatientswithprimarysclerosingcholangitis
AT koschnyronald effectofscheduledendoscopicdilatationofdominantstricturesonoutcomeinpatientswithprimarysclerosingcholangitis
AT stiehladolf effectofscheduledendoscopicdilatationofdominantstricturesonoutcomeinpatientswithprimarysclerosingcholangitis
AT gotthardtdanielnils effectofscheduledendoscopicdilatationofdominantstricturesonoutcomeinpatientswithprimarysclerosingcholangitis
AT sauerpeter effectofscheduledendoscopicdilatationofdominantstricturesonoutcomeinpatientswithprimarysclerosingcholangitis